Thursday, November 12, 2026

EUR/CHF Bearish By 1% In The Last 21 Sessions

EUR/CHF Bearish By 1% In The Last 21 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.87% for the last 21 sessions. At 21:07 EST on Tuesday, 30 July, EUR/CHF (EURCHF) is $0.95.

EUR/CHF's yearly highs and lows, it's 5.67% up from its 52-week low and 3.907% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.28%, a negative 0.06%, and a positive 0.26%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.44% (last week), 0.26% (last month), and 0.26% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be overbought (>=80).

News about

  • Eur/usd extends upside above 1.0850, eyes on eurozone gdp, fed rate decision. According to FXStreet on Monday, 29 July, "The EUR/USD pair trades with mild gains around 1.0860 during the early Asian trading hours on Monday. "
  • Eur/usd price analysis: moves above 1.0850 toward the upper boundary of channel. According to FXStreet on Monday, 29 July, "However, the 14-day Relative Strength Index (RSI), a momentum indicator, is still positioned above the 50 level, suggesting a bullish sentiment for the EUR/USD pair. ", "The EUR/USD pair could test a potential resistance at the upper boundary of the descending channel around the level of 1.0890, followed by the psychological level of 1.0900. "
  • Pure excitement in eur/usd – commerzbank. According to FXStreet on Monday, 29 July, "This week will be one of the most exciting weeks for EUR/USD in a long time, with the first estimate of euro area Q2 GDP due Tuesday, followed by euro area July inflation and the Federal Reserve (Fed) meeting on Wednesday, and US payrolls on Friday, Commerzbank's FX analyst Michael Pfister notes."
  • Eur/usd price analysis: oscillates in a range above 100-day SMA ahead of German CPI. According to FXStreet on Tuesday, 30 July, "Apart from this, key US macro data scheduled at the start of a new month, including the Nonfarm Payrolls (NFP) report on Friday, will be looked for cues about the Federal Reserve's (Fed) rate-cut path, which, in turn, will influence the USD and the EUR/USD pair.", "level near the 1.0730 area, below which the EUR/USD pair is likely to challenge the June monthly swing low, around the 1.0660 region, with some intermediate support near the 1.0700 round-figure mark."

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com